filmov
tv
Covid Vaccine Adverse Reaction and Bereaved Groups
Показать описание
UK Covid-19 Inquiry, 14 January 2025
Anna Morris KC, Covid Vaccine Adverse Reaction and Bereaved Groups.
Biologyphenom substack
UK CV Family
Vaccine Injured and Bereaved UK
Scottish Vaccine Injury Group.
The thousands of people that these three groups represent present what is an uncomfortable truth for many: that vaccine injury and death are part of the pandemic story.
Those I represent are neither anti-science nor are they anti-vaccine. They are real people with real experiences.
My Lady, this Inquiry must recognise and acknowledge the real experiences of the vaccine injured and bereaved, and their need for real treatment, real care, and the need for real change in the way that vaccine
injuries are reported and addressed. For too long they have been ignored by the government, public health bodies and the media.
The Covid Vaccine Adverse Reaction and Bereaved are not just an unfortunate statistic or collateral damage of the government's vaccination strategy. They are individuals and families calling upon the health service and the government for urgent help.
So, my Lady, what does the Inquiry need to understand about the Covid Vaccine Adverse Reaction and Bereaved in this module? First, the Inquiry must understand the decisions that were made around the production, regulation, and rollout of the Covid-19 vaccines.
The groups I represent question what was a so-called acceptable risk of the Covid-19 vaccines to them, and 117 Groups also want to understand the data available to the companies from their clinical randomised trial data and how this information was presented to the UK regulators.
Where vaccines were scaled up from those tests in clinical trials, were the regulators presented with accurate safety data for the products that were in fact rolled out to the public? We also ask how do the MHRA and the JCVI scrutinise data, particularly with regard to those who commenced but did not complete the trials?
Second, my Lady, the Inquiry must understand the post-rollout surveillance and monitoring of the vaccines. Although the desire for a vaccine at speed
may have been understandable, the fast-track process for the development and rollout that followed meant that the stringent post-authorisation surveillance and monitoring was essential, as was public education and information on how to identify and report any adverse reactions to the vaccine.
Essentially, the vaccine rollout put everyone in the UK in a phase IV post-authorisation trial. We were the real-world data that Mr Keith KC referred to this morning. This made it imperative for the government and the NHS to ensure that there was an effective system in place that was well organised and signal sensitive to monitor, detect, and treat any adverse effects.
Anna Morris KC, Covid Vaccine Adverse Reaction and Bereaved Groups.
Biologyphenom substack
UK CV Family
Vaccine Injured and Bereaved UK
Scottish Vaccine Injury Group.
The thousands of people that these three groups represent present what is an uncomfortable truth for many: that vaccine injury and death are part of the pandemic story.
Those I represent are neither anti-science nor are they anti-vaccine. They are real people with real experiences.
My Lady, this Inquiry must recognise and acknowledge the real experiences of the vaccine injured and bereaved, and their need for real treatment, real care, and the need for real change in the way that vaccine
injuries are reported and addressed. For too long they have been ignored by the government, public health bodies and the media.
The Covid Vaccine Adverse Reaction and Bereaved are not just an unfortunate statistic or collateral damage of the government's vaccination strategy. They are individuals and families calling upon the health service and the government for urgent help.
So, my Lady, what does the Inquiry need to understand about the Covid Vaccine Adverse Reaction and Bereaved in this module? First, the Inquiry must understand the decisions that were made around the production, regulation, and rollout of the Covid-19 vaccines.
The groups I represent question what was a so-called acceptable risk of the Covid-19 vaccines to them, and 117 Groups also want to understand the data available to the companies from their clinical randomised trial data and how this information was presented to the UK regulators.
Where vaccines were scaled up from those tests in clinical trials, were the regulators presented with accurate safety data for the products that were in fact rolled out to the public? We also ask how do the MHRA and the JCVI scrutinise data, particularly with regard to those who commenced but did not complete the trials?
Second, my Lady, the Inquiry must understand the post-rollout surveillance and monitoring of the vaccines. Although the desire for a vaccine at speed
may have been understandable, the fast-track process for the development and rollout that followed meant that the stringent post-authorisation surveillance and monitoring was essential, as was public education and information on how to identify and report any adverse reactions to the vaccine.
Essentially, the vaccine rollout put everyone in the UK in a phase IV post-authorisation trial. We were the real-world data that Mr Keith KC referred to this morning. This made it imperative for the government and the NHS to ensure that there was an effective system in place that was well organised and signal sensitive to monitor, detect, and treat any adverse effects.
Комментарии